Lademirsen
Modify Date: 2024-01-11 07:02:45
Lademirsen structure
|
Common Name | Lademirsen | ||
|---|---|---|---|---|
| CAS Number | 1404019-95-9 | Molecular Weight | N/A | |
| Density | N/A | Boiling Point | N/A | |
| Molecular Formula | N/A | Melting Point | N/A | |
| MSDS | N/A | Flash Point | N/A | |
Use of LademirsenLademirsen (SAR339375; RG-012) is a highly specific antisense oligonucleotide (ASO) targeting miR-21. Lademirsen has the potential for Alport nephropathy research[1][2]. |
| Name | Lademirsen |
|---|
| Description | Lademirsen (SAR339375; RG-012) is a highly specific antisense oligonucleotide (ASO) targeting miR-21. Lademirsen has the potential for Alport nephropathy research[1][2]. |
|---|---|
| Related Catalog | |
| In Vivo | Administration of Lademirsen (SAR339375; RG-012) to inhibit miR-21 leads to a slowed progression of renal fibrosis and an increased lifespan in Alport syndrome mouse models[1]. |
| References |
| No Any Chemical & Physical Properties |